An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...
Take A Breather Foundation, a Narberth-based nonprofit, provides much-needed stress relief outlet for individuals living with ...
Once-daily vanzacaftor-tezacaftor-deutivacaftor was safe and well-tolerated in children with cystic fibrosis, while ...
8d
IFLScience on MSNInhalable Cystic Fibrosis Gene Therapy 24 Years In The Making Enters Clinical TrialsA new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey ...
Parents are expressing concerns over an effort at the State House to eliminate the New Hampshire Vaccine Association, with some asking lawmakers to consider the plight of children who face significant ...
Ingelheim, Germany, 20 February 2025 – Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of ...
Vertex Pharmaceuticals (VRTX) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted an opinion ...
Some parents are worried about legislation moving forward at the State House that would dissolve the New Hampshire Vaccine ...
Researchers trial inhalable gene therapy for cystic fibrosis, offering a potential breakthrough in treating the genetic lung ...
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results